Toggle navigation
Home
Search
Services
Blog
Contact
About
AIDS for Clinical and Epidemiological Meta Analysis
Fram, David M.
Belmont Research, Inc., Cambridge, MA, United States
Search 21 grants from David Fram
Search grants from Belmont Research, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Effectiveness Trial of Methods for Engaging Parents Into Parenting Interventions
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology
Metabolic Strategies of Latent Mycobacterium Tuberculosis
Reagent Resource Support for AIDS Vaccine Development
Exceptional Financial Need Scholarships
Recently added grants:
Novel pathways that regulate DNA double-strand break repair events in mammalian cells
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia
Vascular Targeting of Nanocarriers for RNA
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies
Dendritic Mechanisms Underlying Behaviorally-Relevant Activity in a Descending Auditory Pathway
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44RR008840-03
Application #
2284094
Study Section
Special Emphasis Panel (ZRG7-SSS-9 (14))
Program Officer
Filart, Rosemarie
Project Start
1993-08-15
Project End
1998-04-30
Budget Start
1996-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Belmont Research, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02140
Related projects
NIH 1996
R44 RR
AIDS for Clinical and Epidemiological Meta Analysis
Fram, David M. / Belmont Research, Inc.
NIH 1995
R44 RR
AIDS for Clinical and Epidemiological Meta Analysis
Fram, David M. / Belmont Research, Inc.
Comments
Be the first to comment on this grant